Clinical trial
A Phase I, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects
NCT03092102 is registered in ClinicalTrials.gov with Sunshine Lake Pharma Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects
- Lead sponsor
- Sunshine Lake Pharma Co., Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- May 20, 2017
- Completion date
- February 25, 2019
- Enrollment
- 136 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.